The Journal of Pathology: Clinical Research (May 2024)

Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer

  • Phimmada Hatthakarnkul,
  • Kathryn Pennel,
  • Peter Alexander,
  • Hester vanWyk,
  • Antonia Roseweir,
  • Jitwadee Inthagard,
  • Jennifer Hay,
  • Ditte Andersen,
  • Noori Maka,
  • James Park,
  • Campbell Roxburgh,
  • Chanitra Thuwajit,
  • Donald McMillan,
  • Joanne Edwards

DOI
https://doi.org/10.1002/2056-4538.12374
Journal volume & issue
Vol. 10, no. 3
pp. n/a – n/a

Abstract

Read online

Abstract Colorectal cancer (CRC) is a heterogenous malignancy and research is focused on identifying novel ways to subtype patients. In this study, a novel classification system, tumour microenvironment score (TMS), was devised based on Klintrup–Mäkinen grade (KMG), tumour stroma percentage (TSP), and tumour budding. TMS was performed using a haematoxylin and eosin (H&E)‐stained section from retrospective CRC discovery and validation cohorts (n = 1,030, n = 787). TMS0 patients had high KMG, TMS1 were low for KMG, TSP, and budding, TMS2 were high for budding, or TSP and TMS3 were high for TSP and budding. Scores were assessed for association with survival and clinicopathological characteristics. Mutational landscaping and Templated Oligo‐Sequencing (TempO‐Seq) profiling were performed to establish differences in the underlying biology of TMS. TMS was independently prognostic in both cohorts (p < 0.001, p < 0.001), with TMS3 predictive of the shortest survival times. TMS3 was associated with adverse clinical features including sidedness, local and distant recurrence, higher T stage, higher N stage, and presence of margin involvement. Gene set enrichment analysis of TempO‐Seq data showed higher expression of genes associated with hallmarks of cancer pathways including epithelial to mesenchymal transition (p < 0.001), IL2 STAT5 signalling (p = 0.007), and angiogenesis (p = 0.017) in TMS3. Additionally, enrichment of immunosuppressive immune signatures was associated with TMS3 classification. In conclusion, TMS represents a novel and clinically relevant method for subtyping CRC patients from a single H&E‐stained tumour section.

Keywords